UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
August 24, 2005 (August 23, 2005)
U.S. PHYSICAL THERAPY, INC.
(Exact name of registrant as specified in its charter)
Nevada 1-11151 76-0364866
------ ------- ----------
(State or other jurisdiction of (Commission (I.R.S. Employer
incorporation or organization) File Number) Identification No.)
1300 West Sam Houston Parkway South, Suite 300, Houston, Texas 77042
--------------------------------------------------------------- -----
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (713) 297-7000
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17
CFR 240.14a-12(b))
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events
On August 23, 2005, the Company announced that its Board of Directors has
authorized the purchase of up to an additional 500,000 shares of the Company's
outstanding common stock. Shares available for repurchase under an existing
program plus the program announced on August 23, 2005 total over 650,000 shares.
It is expected that shares will be acquired from time to time in open market or
private transactions. No expiration date for the repurchase plan was set.
Currently, there are approximately 12,000,000 shares of U.S. Physical Therapy
common stock outstanding. The Company intends to hold purchased shares in
treasury or to use such shares for other corporate purposes as specified by the
Board.
Item 9.01 Financial Statements and Exhibits
(a) None.
(b) None.
(c) Exhibits
Exhibits Description of Exhibits
-------- -----------------------
99.1 Press Release Dated August 23, 2005.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
U.S. PHYSICAL THERAPY, INC.
Dated: August 24, 2005 By: /s/ LAWRANCE W. MCAFEE
----------------------
Lawrance W. McAfee
Chief Financial Officer
(duly authorized officer and principal
financial and accounting officer)
INDEX TO EXHIBITS
EXHIBIT DESCRIPTION OF EXHIBIT
------- ----------------------
99.1 Press Release dated August 23, 2005.*
* Furnished herewith